Stay updated on Tiragolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab in Lung Cancer Clinical Trial page.

Latest updates to the Tiragolumab in Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedRecruitment status updated to no longer enrolling; new navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention label formatting was updated to Intervention/Treatment, with the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check11 days agoChange DetectedRevision: v3.5.5 is now displayed, replacing Revision: v3.5.4 on the page. This indicates a page revision update.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new Revision tag, v3.5.4, appears on the page, replacing the previous v3.5.3. This represents a minor update to the page metadata or content.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page footer “Revision” number has been updated from v3.5.2 to v3.5.3, reflecting a site/version change rather than an update to the clinical trial information.SummaryDifference0.0%

- Check60 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check68 days agoChange DetectedPadova, Veneto, Italy 35128 was added to the study locations and Padua, Veneto, Italy 35128 was removed.SummaryDifference0.0%

Stay in the know with updates to Tiragolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab in Lung Cancer Clinical Trial page.